ESMO issues guidance about biomarker testing, researchers break down coronavirus risk by cancer type, and the FDA approves liquid biopsy test across tumor types.

by Marci A. Landsmann

A combination of targeted therapies may be effective in people with bile duct cancers, and recent chemotherapy is not associated with worse outcomes from COVID-19.

by Kate Yandell

Lung cancer death rates are on the decline, and a daughter mourns her mother's death from cancer during the pandemic.

by Marci A. Landsmann

A study shows that new cancer diagnoses declined in March and April 2020, and the Food and Drug Administration approves a treatment for multiple myeloma.

by Kate Yandell

New cervical cancer screening guidelines emphasize the role of HPV testing, and a study shows a steep decline in health care visits by people with cancer in spring 2020.

by Kate Yandell

People who have been diagnosed with cancer are more likely than those without a cancer history to adhere to measures like wearing masks and avoiding crowded areas, and CAR-T cell therapy is becoming an option for treating more types of cancer.

by Kate Yandell

A clinical trial suggests that some people with breast cancer may be able to receive radiation therapy over fewer sessions, and a survey shows that the coronavirus pandemic is stressing organizations that provide support to cancer patients.

by Kate Yandell

Upcoming guidelines for lung cancer screening could make more African Americans and women eligible, and the Food and Drug Administration approves a new oral treatment for myelodysplastic syndromes.

by Kate Yandell

A study finds that incidence of thyroid cancer rose by 169% between 1990 and 2017, and the Food and Drug Administration approves a version of a breast cancer treatment that can be given at home.

by Kate Yandell

A study finds that hereditary mutations are elevated in early-onset cancers, and initiatives aim to improve treatment for children with cancer.

by Kate Yandell and Marci A. Landsmann